Inomax DSIR— 510(k) K211153

Name: FDA 510(k) clearance K211153
Creator: U.S. Food and Drug Administration
Published: 2023-04-20

Substantially Equivalent

Mallinckrodt Manufacturing, LLC

FDA 510(k) clearance K211153 for Inomax DSIR, Substantially Equivalent on 2023-04-20. Applicant: Mallinckrodt Manufacturing, LLC. Device class: 2.

Clearance details

Applicant: Mallinckrodt Manufacturing, LLC
Product code: Code MRN
Device class: Class 2
Regulation: 21 CFR 868.5165
Advisory panel: Anesthesiology
Date received: 2021-04-19
Decision date: 2023-04-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Madison, WI, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MRN

view all

K242374 — ULSPIRA TS Nitric Oxide Therapy System2025-01-17
K242578 — EVOLVE Nitric Oxide Delivery System2025-01-03
K240410 — EVOLVE Nitric Oxide Delivery System2024-05-28
K233251 — NOxBOXi Nitric Oxide Delivery System2024-05-23
K222930 — Evolve Nitric Oxide Delivery System2023-12-06

More clearances from Mallinckrodt Manufacturing, LLC

view all

K200389 — INOmax DSIR Plus2020-06-17

Adverse events under product code MRN

product code MRN

Death: 9
Malfunction: 910
Total: 919

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.